Company profile: BioMed Diagnostics
1.1 - Company Overview
Company description
- Provider of highly selective pre-plated prepared media culture devices that combine inoculation, culture, transport, and result analysis to reduce lab labor and costs. Solutions span clinical, veterinary point-of-care, and industrial microbiology for environmental monitoring and compliance, including InPouch, InTray, and PCR-compatible Transit Tube.
Products and services
- InPouch: A resealable pouch combining inoculation, transport, incubation, and result analysis within one device for microbiological diagnostics
- InTray: A stackable tray featuring a media well and anti-fog viewing window for use on a microscope stage in microbiological diagnostics
- Prepared Media Devices: Pre-poured prepared-media devices that combine inoculation, culture, transport, and result into a single unit, reducing lab labor and costs in clinical microbiology
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BioMed Diagnostics
Mymetics
HQ: Switzerland
Website
- Description: Provider of virosome-based vaccine R&D and immunotherapies, focused on next-generation preventative vaccines for infectious diseases. Pipeline includes HIV-1/AIDS, intranasal influenza, malaria, herpes simplex virus and RSV, plus candidates for Covid-19 and COP allergy immunotherapy, and research collaborations in cancer immunotherapy. Swiss-based with a research lab in the Netherlands.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mymetics company profile →
SaNOtize
HQ: Canada
Website
- Description: Provider of platform-based nitric oxide topical therapies for upper respiratory and dermal infections, including a Nitric Oxide Nasal Spray (NONS) that reduces respiratory viral RNA load within 24–72 hours, a physician-provided Foot Cleanser for plantar warts, and a Gel Cleanser for nails and skin in development, with additional cleansers and wellness products planned for US launch in 2025–2026.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SaNOtize company profile →
Utility Therapeutics
HQ: United Kingdom
Website
- Description: Provider of antibiotics focused on combating multi-drug resistant bacterial infections in the US, including PIVYA (pivmecillinam, oral) for UTIs with a unique mode of action addressing resistance, and mecillinam (IV) targeting penicillin binding protein-2 in gram-negative bacteria and stable against β-lactamase hydrolysis, plus a development program working with the FDA to make PIVYA tablets available for uncomplicated UTIs in the US.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Utility Therapeutics company profile →
Sunshine Biopharma
HQ: United States
Website
- Description: Provider of research, development, and commercialization of drugs for the treatment of various forms of cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sunshine Biopharma company profile →
Mesa Biotech
HQ: United States
Website
- Description: Provider of DNA and RNA molecular testing services and COVID-19 diagnostic products, including the Accula SARS-CoV-2 molecular test and testing kits with high-throughput and rapid tests, controls, combo kits, reagents, and buffers. Based in San Diego, California, with a satellite testing laboratory in Santa Fe, New Mexico.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mesa Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BioMed Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BioMed Diagnostics
2.2 - Growth funds investing in similar companies to BioMed Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BioMed Diagnostics
4.2 - Public trading comparable groups for BioMed Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →